{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:07:38Z","timestamp":1789412858838,"version":"build-2803163510"},"reference-count":124,"publisher":"Impact Journals, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,3,31]]},"DOI":"10.18632\/aging.102988","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T12:45:31Z","timestamp":1585658731000},"page":"6492-6510","source":"Crossref","is-referenced-by-count":74,"title":["Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections"],"prefix":"10.18632","volume":"12","author":[{"given":"Alex","family":"Zhavoronkov","sequence":"first","affiliation":[{"name":"Insilico Medicine, Hong Kong Science and Technology Park (HKSTP), Tai Po, Hong Kong"},{"name":"The Biogerontology Research Foundation, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging.","volume":"15","author":"Kroemer","year":"2013","journal-title":"Cell"},{"key":"2","doi-asserted-by":"publisher","first-page":"e22597","DOI":"10.1371\/journal.pone.0022597","article-title":"Methods for structuring scientific knowledge from many areas related to aging research.","volume":"6","author":"Cantor","year":"2011","journal-title":"PLoS One"},{"key":"3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1126\/science.aay7319","article-title":"To help aging populations, classify organismal senescence.","volume":"36","author":"Antebi","year":"2019","journal-title":"Science"},{"key":"4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3389\/fgene.2015.00326","article-title":"Classifying aging as a disease in the context of ICD-11.","volume":"6","author":"Bhullar","year":"2015","journal-title":"Front Genet"},{"key":"5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fgene.2016.00017","article-title":"Editorial: Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives.","volume":"7","author":"Moskalev","year":"2016","journal-title":"Front Genet"},{"key":"6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10522-010-9287-2","article-title":"Aging, frailty and age-related diseases.","volume":"1","author":"Pawelec","year":"2010","journal-title":"Biogerontology"},{"key":"7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mib.2015.11.003","article-title":"Infection in an aging population.","volume":"2","author":"Bowdish","year":"2016","journal-title":"Curr Opin Microbiol"},{"key":"8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.arr.2010.08.003","article-title":"Persistent viral infections and immune aging.","volume":"1","author":"Grubeck-Loebenstein","year":"2011","journal-title":"Ageing Res Rev"},{"key":"9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.arr.2003.07.002","article-title":"Lung infections and aging.","volume":"3","author":"Meyer","year":"2004","journal-title":"Ageing Res Rev"},{"key":"10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1086\/313792","article-title":"Epidemiology and unique aspects of aging and infectious diseases.","volume":"3","author":"Yoshikawa","year":"2000","journal-title":"Clin Infect Dis"},{"key":"11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jinf.2020.02.018","article-title":"Characteristics of COVID-19 infection in Beijing.","volume":"8","author":"Li","year":"2020","journal-title":"J Infect"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19). 2020; 2:113-122.","DOI":"10.46234\/ccdcw2020.032"},{"key":"13","unstructured":"Worldometer. COVID-19 Coronavirus Outbreak. https:\/\/www.worldometers.info\/coronavirus\/."},{"key":"14","unstructured":"Levitt. Analysis of Coronavirus 2019 Data. https:\/\/csblab.github.io\/novoCoronavirus-Analysis\/."},{"key":"15","doi-asserted-by":"crossref","unstructured":"Mizumoto, Kagaya, Zarebski, Chowell. Estimating the Asymptomatic Proportion of 2019 Novel Coronavirus onboard the Princess Cruises Ship, 2020. medRxiv. https:\/\/doi.org\/10.1101\/2020.02.20.20025866.","DOI":"10.1101\/2020.02.20.20025866"},{"key":"16","unstructured":"Ritchie, Roser. Causes of Death. Our World in Data. February 2018. https:\/\/ourworldindata.org\/causes-of-death."},{"key":"17","unstructured":"Global Burden of Disease. The Lancet. https:\/\/www.thelancet.com\/gbd."},{"key":"18","unstructured":"Actuarial Life Table. https:\/\/www.ssa.gov\/oact\/STATS\/table4c6.html."},{"key":"19","unstructured":"Centers for Disease Control. Estimated Influenza Illnesses, Medical visits, Hospitalizations, and Deaths in the United States \u2014 2017-2018 influenza season. https:\/\/www.cdc.gov\/flu\/about\/burden\/2017-2018.htm."},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China.","author":"Zeng","year":"2020","journal-title":"N Engl J Med"},{"key":"21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/path.2104","article-title":"Immunosenescence of ageing.","volume":"21","author":"Sempowski","year":"2007","journal-title":"J Pathol"},{"key":"22","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1183\/09031936.00229714","article-title":"Mechanisms of development of multimorbidity in the elderly.","volume":"4","author":"Barnes","year":"2015","journal-title":"Eur Respir J"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1038\/d41587-020-00003-1","article-title":"Coronavirus puts drug repurposing on the fast track.","author":"Harrison","year":"2020","journal-title":"Nat Biotechnol"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases.","author":"Albaiu","year":"2020","journal-title":"ACS Central Science"},{"key":"25","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1172\/JCI7558","article-title":"Analysis of the human thymic perivascular space during aging.","volume":"10","author":"Hale","year":"1999","journal-title":"J Clin Invest"},{"key":"26","doi-asserted-by":"publisher","first-page":"7446","DOI":"10.4049\/jimmunol.174.11.7446","article-title":"The influence of age on T cell generation and TCR diversity.","volume":"17","author":"Goronzy","year":"2005","journal-title":"J Immunol"},{"key":"27","doi-asserted-by":"publisher","first-page":"e024268","DOI":"10.1136\/bmjopen-2018-024268","article-title":"Prevalence and patterns of multimorbidity among the elderly in China: a cross-sectional study using national survey data.","volume":"9","author":"Chang","year":"2019","journal-title":"BMJ Open"},{"key":"28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12877-019-1173-4","article-title":"Measuring multimorbidity in older adults: comparing different data sources.","volume":"1","author":"Vasiliadis","year":"2019","journal-title":"BMC Geriatr"},{"key":"29","unstructured":"Home-Targeting 2019-nCoV Portal. https:\/\/ghddi-ailab.github.io\/Targeting2019-nCoV\/."},{"key":"30","unstructured":"ClinicalTrials.gov. Search of: Recruiting, Not yet recruiting, Available Studies | \u201cCoronavirus Infections\u201d - List Results - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/search\/open\/condition=%22Coronavirus+Infections%22."},{"key":"31","unstructured":"Centers for Disease Control andPrevention. Influenza Antiviral Medications: Clinician Summary. 2020. https:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/summary-clinicians.htm."},{"key":"32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1086\/422646","article-title":"Detection and control of influenza outbreaks in well-vaccinated nursing home populations.","volume":"3","author":"Ohmit","year":"2004","journal-title":"Clin Infect Dis"},{"key":"33","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13054-019-2491-9","article-title":"Influenza virus-related critical illness: prevention, diagnosis, treatment.","volume":"2","author":"Uyeki","year":"2019","journal-title":"Crit Care"},{"key":"34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.18773\/austprescr.2019.013","article-title":"Influenza: overview on prevention and therapy.","volume":"4","author":"Dwyer","year":"2019","journal-title":"Aust Prescr"},{"key":"35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/vaccines2020297","article-title":"Vaccine Potentiation by Combination Adjuvants.","volume":"2","author":"van Drunen Littel-van den Hurk","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","article-title":"Immunosenescence and human vaccine immune responses.","volume":"1","author":"Kennedy","year":"2019","journal-title":"Immun Ageing"},{"key":"37","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1046\/j.1532-5415.2001.49204.x","article-title":"Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population.","volume":"4","author":"Ward","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-8976-8_1","article-title":"Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus.","volume":"191","author":"Chung","year":"2019","journal-title":"Methods Mol Biol"},{"key":"39","doi-asserted-by":"publisher","first-page":"g2545","DOI":"10.1136\/bmj.g2545","article-title":"Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.","volume":"34","author":"Heneghan","year":"2014","journal-title":"BMJ"},{"key":"40","doi-asserted-by":"publisher","first-page":"g2547","DOI":"10.1136\/bmj.g2547","article-title":"Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.","volume":"34","author":"Jefferson","year":"2014","journal-title":"BMJ"},{"key":"41","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","article-title":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.","volume":"38","author":"Monto","year":"2015","journal-title":"Lancet"},{"key":"42","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.","volume":"37","author":"Arai","year":"2018","journal-title":"N Engl J Med"},{"key":"43","doi-asserted-by":"publisher","first-page":"w20216","DOI":"10.4414\/smw.2020.20216","article-title":"Understanding COVID-19 new diagnostic guidelines - a message of reassurance from an internal medicine doctor in Shanghai.","volume":"15","author":"Ferretti","year":"2020","journal-title":"Swiss Med Wkly"},{"key":"44","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41577-019-0177-9","article-title":"Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?","volume":"1","author":"Lord","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"45","doi-asserted-by":"publisher","first-page":"e13028","DOI":"10.1111\/acel.13028","article-title":"Reversal of epigenetic aging and immunosenescent trends in humans.","volume":"1","author":"Horvath","year":"2019","journal-title":"Aging Cell"},{"key":"46","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","article-title":"DNA methylation age of human tissues and cell types.","volume":"1","author":"Horvath","year":"2013","journal-title":"Genome Biol"},{"key":"47","doi-asserted-by":"publisher","first-page":"14692","DOI":"10.18632\/oncotarget.24461","article-title":"Vive la radior\u00e9sistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization.","volume":"9","author":"Alchinova","year":"2018","journal-title":"Oncotarget"},{"key":"48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fgene.2014.00049","article-title":"Signaling pathway cloud regulation for in silico screening and ranking of the potential geroprotective drugs.","volume":"5","author":"Moskalev","year":"2014","journal-title":"Front Genet"},{"key":"49","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.18632\/aging.101047","article-title":"In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state.","volume":"8","author":"Swick","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.arr.2018.11.003","article-title":"Artificial intelligence for aging and longevity research: recent advances and perspectives.","volume":"4","author":"Aliper","year":"2019","journal-title":"Ageing Res Rev"},{"key":"51","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.18632\/aging.101319","article-title":"Towards natural mimetics of metformin and rapamycin.","volume":"9","author":"Zhavoronkov","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12979-017-0111-6","article-title":"Interventions to restore appropriate immune function in the elderly.","volume":"1","author":"Lang","year":"2018","journal-title":"Immun Ageing"},{"key":"53","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/acel.12585","article-title":"The DrugAge database of aging-related drugs.","volume":"1","author":"Budovsky","year":"2017","journal-title":"Aging Cell"},{"key":"54","doi-asserted-by":"publisher","first-page":"616","DOI":"10.18632\/aging.100799","article-title":"Geroprotectors.org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease.","volume":"7","author":"Scerbacov","year":"2015","journal-title":"Aging (Albany NY)"},{"key":"55","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1126\/science.1115535","article-title":"Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients.","volume":"31","author":"Kennedy","year":"2005","journal-title":"Science"},{"key":"56","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1101\/gad.1381406","article-title":"Extension of chronological life span in yeast by decreased TOR pathway signaling.","volume":"2","author":"Fields","year":"2006","journal-title":"Genes Dev"},{"key":"57","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.cub.2004.03.059","article-title":"Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway.","volume":"1","author":"Benzer","year":"2004","journal-title":"Curr Biol"},{"key":"58","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1080\/15384101.2015.1071745","article-title":"Target of rapamycin activation predicts lifespan in fruit flies.","volume":"1","author":"Sanz","year":"2015","journal-title":"Cell Cycle"},{"key":"59","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cmet.2012.04.007","article-title":"TOR signaling and rapamycin influence longevity by regulating SKN-1\/Nrf and DAF-16\/FoxO.","volume":"1","author":"Blackwell","year":"2012","journal-title":"Cell Metab"},{"key":"60","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.","volume":"46","author":"Miller","year":"2009","journal-title":"Nature"},{"key":"61","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.4161\/cc.10.24.18486","article-title":"Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice.","volume":"1","author":"Blagosklonny","year":"2011","journal-title":"Cell Cycle"},{"key":"62","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1474-9726.2012.00832.x","article-title":"Rapamycin slows aging in mice.","volume":"1","author":"Miller","year":"2012","journal-title":"Aging Cell"},{"key":"63","doi-asserted-by":"publisher","first-page":"715","DOI":"10.18632\/aging.100496","article-title":"New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53-\/- mice by delaying carcinogenesis.","volume":"4","author":"Antoch","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"64","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.2353\/ajpath.2010.091050","article-title":"Rapamycin extends maximal lifespan in cancer-prone mice.","volume":"17","author":"Blagosklonny","year":"2010","journal-title":"Am J Pathol"},{"key":"65","doi-asserted-by":"publisher","first-page":"793","DOI":"10.18632\/aging.100619","article-title":"Immunostimulatory activity of lifespan-extending agents.","volume":"5","author":"Senovilla","year":"2013","journal-title":"Aging (Albany NY)"},{"key":"66","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation.","volume":"36","author":"Hofbauer","year":"2012","journal-title":"N Engl J Med"},{"key":"67","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.","volume":"1","author":"Brault","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"68","doi-asserted-by":"publisher","first-page":"19405","DOI":"10.18632\/oncotarget.3740","article-title":"Rejuvenating immunity: \u201canti-aging drug today\u201d eight years later.","volume":"6","author":"Blagosklonny","year":"2015","journal-title":"Oncotarget"},{"key":"69","doi-asserted-by":"publisher","first-page":"281","DOI":"10.18632\/aging.100034","article-title":"Validation of anti-aging drugs by treating age-related diseases.","volume":"1","author":"Blagosklonny","year":"2009","journal-title":"Aging (Albany NY)"},{"key":"70","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.4161\/cbt.7.10.6663","article-title":"Prevention of cancer by inhibiting aging.","volume":"7","author":"Blagosklonny","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"71","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.drudis.2007.01.004","article-title":"An anti-aging drug today: from senescence-promoting genes to anti-aging pill.","volume":"1","author":"Blagosklonny","year":"2007","journal-title":"Drug Discov Today"},{"key":"72","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.4161\/cc.5.18.3288","article-title":"Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.","volume":"5","author":"Blagosklonny","year":"2006","journal-title":"Cell Cycle"},{"key":"73","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.3389\/fimmu.2018.02953","article-title":"Selective Effects of mTOR Inhibitor Sirolimus on Na\u00efve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression.","volume":"9","author":"Eiz-Vesper","year":"2018","journal-title":"Front Immunol"},{"key":"74","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1600-6143.2011.03473.x","article-title":"Paradoxical aspects of rapamycin immunobiology in transplantation.","volume":"1","author":"Ford","year":"2011","journal-title":"Am J Transplant"},{"key":"75","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1126\/science.1125676","article-title":"Type 1 interferons and the virus-host relationship: a lesson in d\u00e9tente.","volume":"31","author":"Biron","year":"2006","journal-title":"Science"},{"key":"76","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.virusres.2007.03.015","article-title":"SARS coronavirus and innate immunity.","volume":"13","author":"Baric","year":"2008","journal-title":"Virus Res"},{"key":"77","doi-asserted-by":"publisher","first-page":"45010","DOI":"10.18632\/oncotarget.6878","article-title":"Inhibitors of mTOR in aging and cancer.","volume":"6","author":"Zhavoronkov","year":"2015","journal-title":"Oncotarget"},{"key":"78","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.18632\/aging.100714","article-title":"Gerosuppression in confluent cells.","volume":"6","author":"Blagosklonny","year":"2014","journal-title":"Aging (Albany NY)"},{"key":"79","doi-asserted-by":"publisher","first-page":"23238","DOI":"10.18632\/oncotarget.4836","article-title":"Dual mTORC1\/C2 inhibitors suppress cellular geroconversion (a senescence program).","volume":"6","author":"Blagosklonny","year":"2015","journal-title":"Oncotarget"},{"key":"80","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.intimp.2004.09.008","article-title":"Decreased Cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients.","volume":"5","author":"Pacheco-Silva","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"81","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1600-6143.2010.03407.x","article-title":"Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques.","volume":"1","author":"Larsen","year":"2011","journal-title":"Am J Transplant"},{"key":"82","doi-asserted-by":"publisher","first-page":"268ra179","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly.","volume":"6","author":"Klickstein","year":"2014","journal-title":"Sci Transl Med"},{"key":"83","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaq1564","article-title":"TORC1 inhibition enhances immune function and reduces infections in the elderly.","volume":"1","author":"Klickstein","year":"2018","journal-title":"Sci Transl Med"},{"key":"84","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1158\/1535-7163.MCT-09-0160","article-title":"NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas.","volume":"8","author":"Yung","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"85","unstructured":"ClinicalTrials.gov. Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly. Nat Biotechnol. 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04139915."},{"key":"86","unstructured":"ClinicalTrials.gov. Search of: Rad001, Certican, Rapamycin, Rapamune. https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=rad001&cntry=&state=&city=&dist=&rslt=With&phase=2."},{"key":"87","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a Tool to Target Aging.","volume":"2","author":"Espeland","year":"2016","journal-title":"Cell Metab"},{"key":"88","unstructured":"ClinicalTrials.gov. Effect of \u201cNicotinamide Mononucleotide\u201d (NMN) on Cardiometabolic Function. https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03432871."},{"key":"89","unstructured":"ClinicalTrials.gov. Effects of Nicotinamide Riboside on Metabolism and Vascular Function. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03501433."},{"key":"90","unstructured":"ClinicalTrials.gov. Nicotinamide Riboside and Metabolic Health. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02835664."},{"key":"91","unstructured":"ClinicalTrials.gov. Nicotinamide Riboside in Systolic Heart Failure. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03423342."},{"key":"92","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00394-019-01919-4","article-title":"Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study.","volume":"5","author":"Nikolaidis","year":"2020","journal-title":"Eur J Nutr"},{"key":"93","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","article-title":"Chronic nicotinamide riboside supplementation is well-tolerated and elevates NADin healthy middle-aged and older adults.","volume":"9","author":"Seals","year":"2018","journal-title":"Nat Commun"},{"key":"94","unstructured":"ClinicalTrials.gov. Plaque Inflammation and Dysfunctional HDL in AIM-HIGH. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00880178."},{"key":"95","unstructured":"ClinicalTrials.gov. Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00461630."},{"key":"96","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/rej.2019.2218","article-title":"Interacting NADand Cell Senescence Pathways Complicate Antiaging Therapies.","volume":"2","author":"Larrick","year":"2019","journal-title":"Rejuvenation Res"},{"key":"97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular immune pathogenesis and diagnosis of COVID-19.","author":"Li","year":"2020","journal-title":"J Pharm Anal"},{"key":"98","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.celrep.2019.07.043","article-title":"Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NADMetabolome and Induces Transcriptomic and Anti-inflammatory Signatures.","volume":"2","author":"Akerman","year":"2019","journal-title":"Cell Rep"},{"key":"99","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fphar.2016.00258","article-title":"Head to Head Comparison of Short-Term Treatment with the NAD(+) Precursor Nicotinamide Mononucleotide (NMN) and 6 Weeks of Exercise in Obese Female Mice.","volume":"7","author":"Morris","year":"2016","journal-title":"Front Pharmacol"},{"key":"100","doi-asserted-by":"publisher","first-page":"e2267","DOI":"10.1371\/journal.pone.0002267","article-title":"Pharmacological inhibition of nicotinamide phosphoribosyltransferase\/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD.","volume":"3","author":"De Smedt","year":"2008","journal-title":"PLoS One"},{"key":"101","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3389\/fimmu.2018.01593","article-title":"CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions.","volume":"9","author":"Guerau-de-Arellano","year":"2018","journal-title":"Front Immunol"},{"key":"102","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1111\/jgs.14969","article-title":"The Clinical Potential of Senolytic Drugs.","volume":"6","author":"Robbins","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"103","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s42255-019-0122-z","article-title":"Cardiac glycosides are broad-spectrum senolytics.","volume":"1","author":"Manshaei","year":"2019","journal-title":"Nat Metab"},{"key":"104","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.","volume":"4","author":"Koerber","year":"2019","journal-title":"EBioMedicine"},{"key":"105","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3945\/an.115.010538","article-title":"Effect of Flavonoids on Upper Respiratory Tract Infections and Immune Function: A Systematic Review and Meta-Analysis.","volume":"7","author":"Hopkins","year":"2016","journal-title":"Adv Nutr"},{"key":"106","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S2213-8587(19)30151-2","article-title":"2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial.","volume":"7","author":"Fontana","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"107","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1017\/S0029665119000636","article-title":"The role of intermittent fasting and meal timing in weight management and metabolic health.","volume":"7","author":"Betts","year":"2020","journal-title":"Proc Nutr Soc"},{"key":"108","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1056\/NEJMra1905136","article-title":"Effects of Intermittent Fasting on Health, Aging, and Disease.","volume":"38","author":"Mattson","year":"2019","journal-title":"N Engl J Med"},{"key":"109","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","article-title":"Regulatory T cells and Foxp3.","volume":"24","author":"Rudensky","year":"2011","journal-title":"Immunol Rev"},{"key":"110","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1053\/j.gastro.2009.10.037","article-title":"Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.","volume":"13","author":"Hancock","year":"2010","journal-title":"Gastroenterology"},{"key":"111","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1128\/MCB.01206-10","article-title":"Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival.","volume":"3","author":"Hancock","year":"2011","journal-title":"Mol Cell Biol"},{"key":"112","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-3-030-24970-0_15","volume-title":"Biomarkers of Human Aging","volume":"10","author":"Larbi","year":"2019"},{"key":"113","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.18632\/aging.100968","article-title":"Deep biomarkers of human aging: application of deep neural networks to biomarker development.","volume":"8","author":"Zhavoronkov","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"114","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fgene.2018.00242","article-title":"Machine Learning on Human Muscle Transcriptomic Data for Biomarker Discovery and Tissue-Specific Drug Target Identification.","volume":"9","author":"Zhavoronkov","year":"2018","journal-title":"Front Genet"},{"key":"115","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors.","volume":"3","author":"Shayakhmetov","year":"2019","journal-title":"Nat Biotechnol"},{"key":"116","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","article-title":"Genome-wide methylation profiles reveal quantitative views of human aging rates.","volume":"4","author":"Rajapakse","year":"2013","journal-title":"Mol Cell"},{"key":"117","doi-asserted-by":"publisher","DOI":"10.1101\/507780","article-title":"Human microbiome aging clocks based on deep learning and tandem of permutation feature importance and accumulated local effects.","author":"Zhavoronkov","year":"2018","journal-title":"bioRxiv"},{"key":"118","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.tips.2019.05.004","article-title":"Deep Aging Clocks: The Emergence of AI-Based Biomarkers of Aging and Longevity.","volume":"4","author":"Mamoshina","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"119","unstructured":"UK National Health Service. SARS (severe acute respiratory syndrome). https:\/\/www.nhs.uk\/conditions\/sars\/."},{"key":"120","unstructured":"Insilico Medicine. Insilico Medicine publishes molecular structures for the key protein target of 2019-nCoV. February 2020. https:\/\/insilico.com\/ncov-sprint\/."},{"key":"121","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.11829102.v2","article-title":"Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches.","author":"Vanhaelen","year":"2020","journal-title":"ChemRxiv"},{"key":"122","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge.","volume":"9","author":"Schacht","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"123","doi-asserted-by":"publisher","first-page":"c6360","DOI":"10.1136\/bmj.c6360","article-title":"Acute respiratory infections are world\u2019s third leading cause of death.","volume":"34","author":"Mayor","year":"2010","journal-title":"BMJ"},{"key":"124","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2.","volume":"6","author":"Cheng","year":"2020","journal-title":"Cell Discov"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102988","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:16:13Z","timestamp":1599077773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":124,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,4,30]]}},"alternative-id":["102988","32229705"],"URL":"https:\/\/doi.org\/10.18632\/aging.102988","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]}}}